Publications by authors named "Chad May"

Claim this Profile
A
Anti-Extra Domain B Splice Variant of Fibronectin Antibody-Drug Conjugate Eliminates Tumors with Enhanced Efficacy When Combined with Checkpoint Blockade.
Andrea T Hooper, Kimberly Marquette, Chao-Pei Betty Chang, Jonathon Golas, Sadhana Jain, Chad May

Mol Cancer Ther· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regression of EGFR positive established solid tumors in mice with the conditionally active T cell engager TAK-186.
Danielle E Dettling, Eilene Kwok, Lucy Quach, Aakash Datt, Jeremiah D Degenhardt, Chad May

J Immunother Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COBRA™: a highly potent conditionally active T cell engager engineered for the treatment of solid tumors.
Anand Panchal, Pui Seto, Russell Wall, Brian J Hillier, Ying Zhu, Chad May

MAbs· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular imaging reveals biodistribution of P-cadherin LP-DART bispecific and trafficking of adoptively transferred T cells in mouse xenograft model.
Vijay R Gupta, Adam Root, Timothy Fisher, Rand Norberg, John David, Chad May

Oncotarget· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the molecular and cellular phenotypes of common mouse syngeneic models with human tumors.
Wenyan Zhong, Jeremy S Myers, Fang Wang, Kai Wang, Justin Lucas, Chad May

BMC Genomics· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A CD3-bispecific molecule targeting P-cadherin demonstrates T cell-mediated regression of established solid tumors in mice.
Timothy S Fisher, Andrea T Hooper, Justin Lucas, Tracey H Clark, Allison K Rohner, Chad May

Cancer Immunol Immunother· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer.
Adam R Root, Wei Cao, Bilian Li, Peter LaPan, Caryl Meade, Maya Arai, Chad May

Antibodies (Basel)· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining antibody-drug conjugates and immune-mediated cancer therapy: What to expect?
Hans-Peter Gerber, Puja Sapra, Frank Loganzo, Chad May

Biochem Pharmacol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in bispecific biotherapeutics for the treatment of cancer.
Chad May, Puja Sapra, Hans-Peter Gerber

Biochem Pharmacol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubes.
Alessandro Ruggiero, Carlos H Villa, Jason P Holland, Shanna R Sprinkle, Chad May

Int J Nanomedicine· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth.
Olaf Penack, Erik Henke, David Suh, Chris G King, Odette M Smith, Chad May

J Natl Cancer Inst· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells.
Jason M Butler, Daniel J Nolan, Eva L Vertes, Barbara Varnum-Finney, Hideki Kobayashi, Chad May

Cell Stem Cell· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective alpha-particle mediated depletion of tumor vasculature with vascular normalization.
Jaspreet Singh Jaggi, Erik Henke, Surya V Seshan, Barry J Kappel, Debjit Chattopadhyay, Chad May

PLoS One· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progress toward the genetic treatment of the beta-thalassemias.
Michel Sadelain, Leszek Lisowski, Selda Samakoglu, Stefano Rivella, Chad May

Ann N Y Acad Sci· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combretastatin A4 phosphate induces rapid regression of tumor neovessels and growth through interference with vascular endothelial-cadherin signaling.
Loïc Vincent, Pouneh Kermani, Lauren M Young, Joseph Cheng, Fan Zhang, Chad May

J Clin Invest· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methotrexate preconditioning allows sufficient engraftment to confer drug resistance in mice transplanted with marrow expressing drug-resistant dihydrofolate reductase activity.
Lalitha R Belur, Rohaizah I James, Chad May, Miechaleen D Diers, Debra Swanson

J Pharmacol Exp Ther· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin.
Katrin Lamszus, Marc A Brockmann, Carmen Eckerich, Peter Bohlen, Chad May

Clin Cancer Res· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a transiently exposed VE-cadherin epitope that allows for specific targeting of an antibody to the tumor neovasculature.
Chad May, Jacqueline F Doody, Rashed Abdullah, Paul Balderes, Xiaohong Xu

Blood· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human beta-globin gene transfer.
Stefano Rivella, Chad May, Amy Chadburn, Isabelle Rivière, Michel Sadelain

Blood· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes.
Guenther Koehne, Mikhail Doubrovin, Ekaterina Doubrovina, Pat Zanzonico, Humilidad F Gallardo, Chad May

Nat Biotechnol· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple stages of malignant transformation of human endothelial cells modelled by co-expression of telomerase reverse transcriptase, SV40 T antigen and oncogenic N-ras.
Karen L MacKenzie, Sonia Franco, Afzal J Naiyer, Chad May, Michel Sadelain

Oncogene· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Limited proliferation and telomere dysfunction following telomerase inhibition in immortal murine fibroblasts.
Jessica Boklan, Gouri Nanjangud, Karen L MacKenzie, Chad May, Michel Sadelain

Cancer Res· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful treatment of murine beta-thalassemia intermedia by transfer of the human beta-globin gene.
Chad May, Stefano Rivella, Amy Chadburn, Michel Sadelain

Blood· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis